H. Lawrence Remmel's most recent trade in Atossa Therapeutics Inc was a trade of 125,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atossa Therapeutics Inc | H. Lawrence Remmel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | H. Lawrence Remmel | Director | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 26 Mar 2025 | 10,000 | 10,257 (0%) | 0% | 0.7 | 7,000 | Common Stock |
| Atossa Therapeutics Inc | H. Lawrence Remmel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | H. Lawrence Remmel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | H. Lawrence Remmel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |